What is Shandong Lukang Pharmaceutical Co.,Ltd.'s (600789.SS) StockRank?

MoatMap's StockRank for Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) is 48/100, with a Hold signal. This is a composite score combining Quality (49), Value (46), and Momentum (43) factor ranks across MoatMap's 19,000+ stock universe.

Does Shandong Lukang Pharmaceutical Co.,Ltd. have an economic moat?

Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shandong Lukang Pharmaceutical Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shandong Lukang Pharmaceutical Co.,Ltd. in?

Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600789.SS

HOLDREMOVE

Shandong Lukang Pharmaceutical Co.,Ltd. · Healthcare · China · $1.2B · Avg Vol: $15M/d

StockRank

P/E (TTM)

90.0x

ROE

1.8%

D/E

0.5x

Dividend %

0.7%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shandong Lukang Pharmaceutical is a legacy Chinese pharmaceutical firm lacking the scale, high-utilization CDMO pricing power, or proprietary biologics platforms required to benefit from our CDMO theme.

COMPANY DESCRIPTION

Shandong Lukang Pharmaceutical Co., Ltd. produces human and veterinary antibiotics, amino acids, and generic pharmaceuticals. The company operates one of China's largest production bases for raw antibiotic materials and finished dosages. It is a vertically integrated pharmaceutical manufacturer with a strong export footprint and deep cost advantages.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	831M	908M	921M	852M	0.9%
EPS	0.02	0.04	0.07	0.02	-9.1%
Shares	887M	896M	899M	1.0B	+17.8%
Debt	422M	425M	420M	454M	2.5%
Equity	496M	534M	579M	756M	15.1%
Op CF	66M	89M	60M	103M	16.3%
Inv CF	-66M	-55M	-38M	-35M	—
Fin CF	-784,551	-14M	-28M	171M	—

PRICE (1M)-14.8%

SMA 50SMA 200

$1.05

RSI (14)

23.0

52W High

$1.67

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

3.4%52.1

ROE

1.8%48.3

GP/Assets

12.3%30.1

Op. Margin

6.4%58.4

FCF/Assets

7.5%80.1

Piotroski

—83.5

Int. Cover

3.5x50.3

D/E Ratio

0.50x31.4

Current Ratio

1.53x25.6

Value

P/E (TTM)

90.0x10.5

EV/EBITDA

12.6x34.2

P/FCF

74.4x82.8

P/B

1.5x67.2

P/S

1.3x78.7

Div Yield

0.7%19.2

Momentum

52W High %

63%45.2

RS 6M

-36%34.0

SMA 50/200

0.88x26.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—97.0

Q Growth

-32%16.8

FUNDAMENTALS

Market Cap

$1.2B

P/E (Forward)

12.4x

Gross Margin

21.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600789.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.(you)	$1.2B	48	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
300026.SZ	Tianjin Chase Sun Pharmaceutical Co.,Ltd	$1.4B	43	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) — Stock Score Summary

Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) has a MoatMap StockRank of 48/100 based on Quality (49/100), Value (46/100), and Momentum (43/100) factor scores. The current signal is HOLD. Shandong Lukang Pharmaceutical is a legacy Chinese pharmaceutical firm lacking the scale, high-utilization CDMO pricing power, or proprietary biologics platforms required to benefit from our CDMO theme.

Key Financial Metrics

Price	$1.05
Market Cap	$1.2B
P/E (TTM)	90.00
P/E (Forward)	12.41
Price/Book	1.46
Return on Equity	1.8%
Return on Invested Capital	3.4%
Debt/Equity	49.85
Gross Margin	21.5%
Operating Margin	6.4%
Revenue Growth	-3.4%
Dividend Yield	0.7%
Free Cash Flow	$16M

Shandong Lukang Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shandong Lukang Pharmaceutical Co.,Ltd.’s (600789.SS) StockRank?: MoatMap’s StockRank for Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) is 48/100, with a Hold signal. It is a composite of Quality (49), Value (46), and Momentum (43) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shandong Lukang Pharmaceutical Co.,Ltd. have an economic moat?: Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shandong Lukang Pharmaceutical Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shandong Lukang Pharmaceutical Co.,Ltd. in?: Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).